Stock Price Forecast

April 24, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading HeartBeam, Inc. chart...

About the Company

We do not have any company description for HeartBeam, Inc. at the moment.

Exchange

Nasdaq

$2B

Total Revenue

18

Employees

$54M

Market Capitalization

-2.28

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $BEAT News

HeartBeam, Inc. (BEAT)

6d ago, source: Yahoo Finance

HeartBeam, Inc. (NASDAQ:BEAT) Q4 2023 Earnings Call Transcript March 20, 2024 HeartBeam, Inc. misses on earnings expectations. Reported EPS is $-0.15 EPS, expectations were $-0.12. BEAT isn’t ...

What's Going On With Heartbeam (BEAT) Stock?

on MSN ago, source:

Heartbeam Inc (NASDAQ:BEAT) shares are trading higher by 3.5% to $2.35 Tuesday, pulling back following the session high of $2 ...

HeartBeam Presents Positive Results on its Artificial Intelligence Capabilities for Detecting Arrhythmias

16d ago, source: Stockhouse

CloseCurlyDoubleQuote; About HeartBeam, Inc. HeartBeam, Inc. (NASDAQ: BEAT) is a medical technology company that is dedicated to transforming cardiac care through the power of personalized insights.

HeartBeam AI Combined With Vectorcardiography Delivers Equivalent Performance To 12-lead ECG

16d ago, source: Business Insider

(RTTNews) - HeartBeam, Inc. (BEAT) announced new data showing that applying the company's artificial intelligence algorithms to vectorcardiography or VCG showed considerably improved performance ...

First Patients Enrolled in Pivotal Study Evaluating HeartBeam’s AIMIGo™ System for Synthesizing a 12-Lead ECG

1mon ago, source: Business Wire

SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through the power of personalized insights, announced today ...

Biomednewsbreaks - Heartbeam Inc. (NASDAQ: BEAT) Releases Financial Results, Corporate Highlights For Q4, FY 2023

1mon ago, source: Mena FN

(MENAFN- Investor Brand Network) HeartBeam (NASDAQ: BEAT) , a medical technology company focused on transforming cardiac care through the power of personalized insights, has announced its ...

Heartbeam Inc.

1mon ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

HeartBeam Presents Positive Results on its Artificial Intelligence Capabilities for Detecting Arrhythmias

16d ago, source: Morningstar

About HeartBeam, Inc. HeartBeam, Inc. (NASDAQ: BEAT) is a medical technology company that is dedicated to transforming cardiac care through the power of personalized insights. The company’s ...

Heartbeam Inc. Wt

1mon ago, source: Barron's

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

HeartBeam, Inc. (BEAT)

1mon ago, source: Yahoo Finance

SANTA CLARA, Calif., March 07, 2024--HeartBeam Receives Two New US Patents for its Core Cardiac Monitoring Technology Business Wire HeartBeam to Host Fourth Quarter and Full Year 2023 Results ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...